Cargando…

ERα, A Key Target for Cancer Therapy: A Review

Estrogen receptor α (ERα) is closely associated with both hormone-dependent and hormone-independent tumors, and it is also essential for the development of these cancers. The functions of ERα are bi-faceted; it can contribute to cancer progression as well as cancer inhibition. Therefore, understandi...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yanfang, Ma, Hong, Yao, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073439/
https://www.ncbi.nlm.nih.gov/pubmed/32210584
http://dx.doi.org/10.2147/OTT.S236532
_version_ 1783506619966947328
author Liu, Yanfang
Ma, Hong
Yao, Jing
author_facet Liu, Yanfang
Ma, Hong
Yao, Jing
author_sort Liu, Yanfang
collection PubMed
description Estrogen receptor α (ERα) is closely associated with both hormone-dependent and hormone-independent tumors, and it is also essential for the development of these cancers. The functions of ERα are bi-faceted; it can contribute to cancer progression as well as cancer inhibition. Therefore, understanding ERα is vital for the treatment of those cancers that are closely associated with its expression. Here, we will elaborate on ERα based on its structure, localization, activation, modification, and mutation. Also, we will look at co-activators of ERα, elucidate the signaling pathway activated by ERα, and identify cancers related to its activation. A comprehensive understanding of ERα could help us to find new ways to treat cancers.
format Online
Article
Text
id pubmed-7073439
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-70734392020-03-24 ERα, A Key Target for Cancer Therapy: A Review Liu, Yanfang Ma, Hong Yao, Jing Onco Targets Ther Review Estrogen receptor α (ERα) is closely associated with both hormone-dependent and hormone-independent tumors, and it is also essential for the development of these cancers. The functions of ERα are bi-faceted; it can contribute to cancer progression as well as cancer inhibition. Therefore, understanding ERα is vital for the treatment of those cancers that are closely associated with its expression. Here, we will elaborate on ERα based on its structure, localization, activation, modification, and mutation. Also, we will look at co-activators of ERα, elucidate the signaling pathway activated by ERα, and identify cancers related to its activation. A comprehensive understanding of ERα could help us to find new ways to treat cancers. Dove 2020-03-11 /pmc/articles/PMC7073439/ /pubmed/32210584 http://dx.doi.org/10.2147/OTT.S236532 Text en © 2020 Liu et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Liu, Yanfang
Ma, Hong
Yao, Jing
ERα, A Key Target for Cancer Therapy: A Review
title ERα, A Key Target for Cancer Therapy: A Review
title_full ERα, A Key Target for Cancer Therapy: A Review
title_fullStr ERα, A Key Target for Cancer Therapy: A Review
title_full_unstemmed ERα, A Key Target for Cancer Therapy: A Review
title_short ERα, A Key Target for Cancer Therapy: A Review
title_sort erα, a key target for cancer therapy: a review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073439/
https://www.ncbi.nlm.nih.gov/pubmed/32210584
http://dx.doi.org/10.2147/OTT.S236532
work_keys_str_mv AT liuyanfang eraakeytargetforcancertherapyareview
AT mahong eraakeytargetforcancertherapyareview
AT yaojing eraakeytargetforcancertherapyareview